Unknown

Dataset Information

0

Skin Autofluorescence, a Noninvasive Biomarker for Advanced Glycation End-products, Is Associated With Sarcopenia.


ABSTRACT:

Background

Accumulation of advanced glycation end-products (AGEs) in skeletal muscle has been implicated in development of sarcopenia.

Aim

To obtain further insight in the pathophysiology of sarcopenia, we studied its relationship with skin AGEs in the general population.

Methods

In a cross-sectional analysis, 2744 participants of northern European background, mean age 74.1 years, were included from the Rotterdam Study. Skin AGEs were measured as skin autofluorescence (SAF) using AGE ReaderTM, appendicular skeletal mass index (ASMI) using insight dual-energy X-ray absorptiometry, hand grip strength (HGS) using a hydraulic hand dynamometer, and, in a subgroup, gait speed (GS) measured on an electronic walkway (n = 2080). We defined probable sarcopenia (low HGS) and confirmed sarcopenia (low HGS and low ASMI) based on the European Working Group on Sarcopenia in Older People (EWGSOP2) revised criteria cutoffs. Multivariate linear and logistic regression were performed adjusting for age, sex, body fat percentage, height, renal function, diabetes, and smoking status.

Results

The prevalence of low ASMI was 7.7%; probable sarcopenia, 24%, slow GS, 3%; and confirmed sarcopenia, 3.5%. SAF was inversely associated with ASMI [β -0.062 (95% CI -0.092, -0.032)], HGS [β -0.051 (95% CI -0.075, -0.026)], and GS [β -0.074 (95% CI -0.116, -0.033)]. A 1-unit increase in SAF was associated with higher odds of probable sarcopenia [odds ratio (OR) 1.36 (95% CI 1.09, 1.68)] and confirmed sarcopenia [OR 2.01 (95% CI 1.33, 3.06)].

Conclusion

Higher skin AGEs are associated with higher sarcopenia prevalence. We call for future longitudinal studies to explore the role of SAF as a potential biomarker of sarcopenia.

SUBMITTER: Waqas K 

PROVIDER: S-EPMC8764216 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Skin Autofluorescence, a Noninvasive Biomarker for Advanced Glycation End-products, Is Associated With Sarcopenia.

Waqas Komal K   Chen Jinluan J   Trajanoska Katerina K   Ikram M Arfan MA   Uitterlinden André G AG   Rivadeneira Fernando F   Zillikens M Carola MC  

The Journal of clinical endocrinology and metabolism 20220101 2


<h4>Background</h4>Accumulation of advanced glycation end-products (AGEs) in skeletal muscle has been implicated in development of sarcopenia.<h4>Aim</h4>To obtain further insight in the pathophysiology of sarcopenia, we studied its relationship with skin AGEs in the general population.<h4>Methods</h4>In a cross-sectional analysis, 2744 participants of northern European background, mean age 74.1 years, were included from the Rotterdam Study. Skin AGEs were measured as skin autofluorescence (SAF)  ...[more]

Similar Datasets

| S-EPMC9536452 | biostudies-literature
| S-EPMC7687120 | biostudies-literature
| S-EPMC8184826 | biostudies-literature
| S-EPMC5450154 | biostudies-other
| S-EPMC7210606 | biostudies-literature
| S-EPMC7695256 | biostudies-literature
| S-EPMC10685533 | biostudies-literature
| S-EPMC6325991 | biostudies-literature
| S-EPMC10787742 | biostudies-literature
| S-EPMC11219223 | biostudies-literature